Related Experiment Video
Updated: Apr 14, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
The implantable cardioverter-defibrillator: An update
Jared D Miller1, Omair Yousuf1, Ronald D Berger1
1Department of Medicine, Johns Hopkins University, Baltimore, MD.
Implantable cardioverter-defibrillators (ICDs) save lives by preventing sudden cardiac death. This review covers clinical trials and programming strategies that optimize ICD therapy and heart failure management.
Area of Science:
- Cardiology
- Medical Devices
- Clinical Trials
Background:
- The implantable cardioverter-defibrillator (ICD) is a critical device for preventing sudden cardiac death.
- Millions of ICDs have been implanted globally since 1980, guided by clinical trial evidence.
- ICDs play a role in both primary and secondary prevention of sudden cardiac death.
Observation:
- Clinical trials have established guidelines for ICD implantation.
- Recent research focuses on programming strategies to minimize inappropriate shocks and enhance patient survival.
- ICDs offer potential benefits for monitoring and managing heart failure.
Findings:
- Evidence supports ICD use in preventing sudden cardiac death.
- Optimized programming strategies improve outcomes for ICD recipients.
- ICDs contribute to comprehensive heart failure management.
Implications:
- ICDs remain a cornerstone therapy for at-risk cardiac patients.
- Ongoing research refines ICD use for improved patient care and survival.
- The role of ICDs in managing heart failure warrants further investigation.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Cardiac Catheterization IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management

